Good Life Advisors’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.96M Sell
83,999
-4,364
-5% -$143K 0.19% 103
2025
Q1
$2.85M Sell
88,363
-1,172
-1% -$39.3K 0.2% 99
2024
Q4
$2.98M Buy
89,535
+5,987
+7% +$202K 0.22% 94
2024
Q3
$2.78M Buy
83,548
+32,254
+63% +$1.03M 0.17% 118
2024
Q2
$1.61M Buy
51,294
+33,508
+188% +$1.02M 0.13% 136
2024
Q1
$538K Buy
+17,786
New +$513K 0.05% 232

Other funds holding TCAF

Good Life Advisors's TCAF Position: Q2 2025 in Review

Good Life Advisors reduced its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 4.9% in Q2 2025, selling an estimated $143K and leaving 83,999 shares worth $2.96M. The position accounts for 0.19% of the portfolio, ranked #103.

Good Life Advisors first reported a position in TCAF in Q1 2024 and has held it in 6 quarters since. The position peaked at $2.98M in Q4 2024. 277 funds tracked by Wall St. Rank hold TCAF as of Q2 2025.

  • Good Life Advisors held 83,999 shares of T. Rowe Price Capital Appreciation Equity ETF worth $2.96M as of Q2 2025.
  • Good Life Advisors sold 4,364 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2025, an estimated $143K.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.19% of Good Life Advisors's portfolio in Q2 2025, its #103 holding.
  • Good Life Advisors first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q1 2024 and has held it in 6 quarters since.
  • Good Life Advisors's T. Rowe Price Capital Appreciation Equity ETF position peaked at $2.98M in Q4 2024.
  • 277 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.